Immediate vs. Deferred Switching from a Boosted Protease Inhibitor (PI/r) Based Regimen to a Dolutegravir (DTG) Based Regimen in Virologically Suppressed Patients with High Cardiovascular Risk or Age ≥50 years: Final 96 Weeks Results of NEAT 022 study

Gatell, José M, Assoumou, Lambert, Moyle, Graeme, Waters, Laura, Johnson, Margaret, Domingo, Pere, Fox, Julie, Martinez, Esteban, Stellbrink, Hans – Jürgen, Guaraldi, Giovanni, Masia, Mar, Gompels, Mark, De Wit, Stephane, Florence, Eric, Esser, Stefan, Raffi, François, Stephan, Christoph, Rockstroh, Juergen, Giacomelli, Andrea, Vera, Jaime, Bernardino, José Ignacio, Winston, Alan, Saumoy, Maria, Gras, Julien, Katlama, Christine and Pozniak, Anton L (2018) Immediate vs. Deferred Switching from a Boosted Protease Inhibitor (PI/r) Based Regimen to a Dolutegravir (DTG) Based Regimen in Virologically Suppressed Patients with High Cardiovascular Risk or Age ≥50 years: Final 96 Weeks Results of NEAT 022 study. Clinical Infectious Diseases. ISSN 1058-4838

[img] PDF - Accepted Version
Restricted to SRO admin only until 14 June 2019.

Download (936kB)
Item Type: Article
Schools and Departments: Brighton and Sussex Medical School > Global Health and Infection
Subjects: R Medicine
Depositing User: Jaime Vera Rojas
Date Deposited: 22 Jun 2018 10:33
Last Modified: 22 Jun 2018 10:33
URI: http://srodev.sussex.ac.uk/id/eprint/76672

View download statistics for this item

📧 Request an update